Dukes on Water is officially closing down on Friday night, May 15.Co-owner Andrea Shafton says the closure is not about safety concerns and has been in the works. “Our family has ...
Chief Executive Officer Sam Kulkarni said the company is entering a “second phase” as it moves beyond the initial launch of ...
Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration ...
The biotechnology companies formed an alliance applying artificial intelligence to small interfering RNA therapeutic ...
Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including antibodies, enzymes, and siRNA, with continued progress across AL037/AL137 (ABC-enabled antibody ...
Sirni ittisa misaa'elaa Pirezidantii US Doonaald Tiraamp ''Golden Dome'' jedhamu ijaaramuuf, bobbaafamuuf (tajaajilaaf ooluuf ...
Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico ...
Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced ...
Detailed price information for Silexion Therapeutics Corp (SLXN-Q) from The Globe and Mail including charting and trades.
New data from the Oregon Health Authority (OHA) is showing a decline in overdose deaths over the past two years. According to ...
Hongene Biotech shows advanced oligonucleotide CDMO capabilities via support of SiranBio’s dual-target siRNA programme: Singapore Saturday, May 9, 2026, 16:00 Hrs [IST] Hongene ...
Combining pre-formed vesicles with nucleic acid cargo at the point of care can remove long-standing barriers to personalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results